Electromed, Inc.

AMEX:ELMD

Medical - Devices

Healthcare
$23.40 +1.16%

+$0.43 today

Market cap
$191.27M
Beta
0.52
P/E (TTM)
30.5
EPS (TTM)
$1.23
52W Low $17.73High $40.00

Volume 0.05M

Average 0.06M

ELMD Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Electromed, Inc.AMEX: ELMD

Net Margin · Q3 FY2026 · quarter ended Mar 2026

Net margin widens to 16.2%

Net margin was 16.2% in Q3 FY2026, up 4.1 pp from a year earlier. On a trailing-twelve-month basis it was 14.1%, up 2.4 pp year over year. Over 3 fiscal years it widened by 6.2 pp.

Context

  • Net margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether net margin reaches the consensus estimate from 2 analysts of 14.4% for the fiscal year ending Jun 2026, up from 11.8% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
16.2%+1.6 pp QoQ
Last fiscal yearJun 2025
11.8%+2.4 pp YoY
LTMMar 2026
14.1%+2.4 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+4.1 pp+1.7 pp-2.4 pp
1 year+2.4 pp+2.6 pp+0.2 pp
3 years+6.2 pp+5.0 pp-1.3 pp
5 years-0.1 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
11.8%
Year-over-year change
+2.4pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How ELMD compares with its peers on the latest reported figures

  • ELMD's LTM Mar 2026 net margin of 14.1% is the 2nd highest of the 6 companies compared; the peer median is 5.2%.
  • Its year-over-year change of +2.4 pp is the 2nd highest of 6, against a peer median of -0.1 pp.
  • Over three fiscal years its change of +6.2 pp compares with a peer median of +5.7 pp.
ELMD Competitors Peer median
Net Margin for ELMD and competitors
Company Period LTM level YoY 3-year change
RMDResMed Inc.LTM Jun 202626.9% -0.3 pp+5.7 pp
ELMDElectromed, Inc.LTM Mar 202614.1% +2.4 pp+6.2 pp
TCMDTactile Systems Technology, Inc.LTM Mar 20265.9% +0.4 pp+13.0 pp
VMDViemed Healthcare, Inc.LTM Mar 20265.2% -0.1 pp+1.0 pp
AHCOAdaptHealth Corp.LTM Apr 2026-2.8% -6.0 pp-4.5 pp
LUNGPulmonx CorporationLTM Mar 2026-60.1% +5.2 pp+50.1 pp
Peer median (excluding ELMD) 5.2%-0.1 pp+5.7 pp

Competitors are the stored peer set for ELMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Revenue35.76M41.66M48.07M54.72M64M
Cost of Revenue8.45M10.22M11.55M12.99M14.03M
Gross Profit27.31M31.44M36.52M41.73M49.97M
Gross Margin76.4%75.5%76.0%76.3%78.1%
Research & Development1.72M1.36M916K656K996K
Selling, General & Admin22.44M27.11M31.6M34.49M39.1M
Operating Expenses24.17M28.47M32.51M35.15M40.1M
Depreciation & Amortization610K628K613K841K1.17M
EBITDA3.78M3.63M4.7M7.88M11.46M
EBITDA Margin10.6%8.7%9.8%14.4%17.9%
Operating Income3.14M2.97M4.01M6.58M9.87M
Operating Margin8.8%7.1%8.3%12.0%15.4%
Interest Income39K25K78K455K624K
Interest Expense00000
Other Income / Expenses27K25K78K455K412K
Income Before Tax3.17M3M4.09M7.04M10.28M
Pre-Tax Margin8.9%7.2%8.5%12.9%16.1%
Income Tax Expense805K692K920K1.89M2.75M
Net Income2.36M2.31M3.17M5.15M7.54M
Net Margin6.6%5.5%6.6%9.4%11.8%
EPS (Basic)0.280.270.370.600.90
EPS (Diluted)0.270.260.360.580.86
Weighted Avg Shares8.57M8.47M8.46M8.56M8.33M
Weighted Avg Shares (Diluted)8.91M8.77M8.7M8.86M8.72M

Electromed, Inc.

AMEX:ELMD

Intrinsic Alpha fair value

Locked

Current Price

$23.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.